Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | BMY | AMGN | GILD | VRTX |
| Company | Denali Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 31.70 | 49.89 | 337.03 | 84.39 | 477.70 |
| High | 31.94 | 50.04 | 338.70 | 84.65 | 483.98 |
| Low | 31.07 | 49.11 | 334.61 | 83.57 | 476.27 |
| Last | 31.23 | 49.56 | 337.13 | 84.26 | 480.24 |
| Change | +0.47 | -0.18 | +4.21 | +0.37 | +6.08 |
| % Change | +1.53% | -0.36% | +1.26% | +0.44% | +1.28% |
| Volume | 458,606 | 3,629,965 | 755,564 | 4,450,511 | 461,261 |
| 20-Day Average Volume | 978,987 | 8,342,419 | 1,715,583 | 6,465,876 | 962,494 |
| Previous Close | 30.76 | 49.74 | 332.92 | 83.89 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.71 | 49.11 | 329.62 | 80.09 | 479.99 |
| 20-Day Raw Stochastic | 90.80% | 65.59% | 88.05% | 94.34% | 49.83% |
| 20-Day Relative Strength | 74.60% | 56.02% | 58.16% | 72.72% | 50.64% |
| Weighted Alpha | +67.62 | -10.20 | +27.44 | +19.11 | +34.51 |
| Today's Opinion | 100% Buy | 72% Buy | 96% Buy | 88% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.05% since 09/12/24 | +2.45% since 09/12/24 | +1.98% since 09/12/24 | +1.43% since 09/12/24 | +0.37% since 09/12/24 |
| Low | 28.00 on 09/13/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 |
| High | 32.13 on 09/18/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +30.81% since 08/19/24 | +0.24% since 08/19/24 | +2.63% since 08/19/24 | +13.30% since 08/19/24 | -1.57% since 08/19/24 |
| Low | 23.29 on 08/20/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 |
| High | 32.13 on 09/18/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +51.94% since 06/18/24 | +21.10% since 06/18/24 | +10.01% since 06/18/24 | +33.57% since 06/18/24 | +2.81% since 06/18/24 |
| Low | 19.74 on 08/05/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 32.13 on 09/18/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +52.53% since 03/19/24 | -4.59% since 03/19/24 | +23.88% since 03/19/24 | +14.90% since 03/19/24 | +15.70% since 03/19/24 |
| Low | 14.56 on 04/25/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 32.13 on 09/18/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,386,653 | 100,827,960 | 178,589,936 | 104,514,608 | 122,358,416 |
| Shares Outstanding, K | 142,609 | 2,027,100 | 536,435 | 1,245,853 | 258,053 |
| Annual Sales | 330,530,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -145,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -99,030,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.37 | 0.46 | 0.61 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 08/01/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/05/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 0.00 |